Biomedicines (Jul 2022)

T-Cell Infiltration and Immune Checkpoint Expression Increase in Oral Cavity Premalignant and Malignant Disorders

  • Subin Surendran,
  • Usama Aboelkheir,
  • Andrew A. Tu,
  • William J. Magner,
  • S. Lynn Sigurdson,
  • Mihai Merzianu,
  • Wesley L. Hicks,
  • Amritha Suresh,
  • Keith L. Kirkwood,
  • Moni A. Kuriakose

DOI
https://doi.org/10.3390/biomedicines10081840
Journal volume & issue
Vol. 10, no. 8
p. 1840

Abstract

Read online

The immune cell niche associated with oral dysplastic lesion progression to carcinoma is poorly understood. We identified T regulatory cells (Treg), CD8+ effector T cells (Teff) and immune checkpoint molecules across oral dysplastic stages of oral potentially malignant disorders (OPMD). OPMD and oral squamous cell carcinoma (OSCC) tissue sections (N = 270) were analyzed by immunohistochemistry for Treg (CD4, CD25 and FoxP3), Teff (CD8) and immune checkpoint molecules (PD-1 and PD-L1). The Treg marker staining intensity correlated significantly (p + effector T cells and the immune checkpoint markers PD-1 and PD-L1 were also associated with oral cancer progression (p p < 0.01). These data indicate the presence of reinforcing mechanisms contributing to the immune suppressive niche in high-risk OPMD and in OSCC. The presence of an adaptive immune response and T-cell exhaustion suggest that an effective immune response may be reactivated with targeted interventions coupled with immune checkpoint inhibition.

Keywords